M&G Investments led a $42m Series C round in Nuritas.

M&G Investments, an investment management services firm, led a $42m Series C round in Nuritas, a biotechnology company, with participation from Mcwin Capital Partners, ECBF, and Grosveno. “We are thrilled to welcome M&G’s Catalyst team and McWin Capital Partners, who share our vision of making healthier ingredients accessible to billions of people globally. This investment, alongside the addition of experienced board members, will propel our mission to new heights,” Nora Khaldi, Nuritas Founder and CEO.